Fuhrman grade and concomitant bisphosphonates as additional prognostic factors in metastatic renal cell carcinoma with bone metastases treated with sunitinib

被引：2
|
作者：
Beuselinck, B. L.
Medioni, J.
Wolter, P.
Blesius, A.
Karadimou, A.
Schbffski, P.
Escudier, B. J.
Zucman-Rossi, J.
Paridaens, R.
Oudard, S.
机构：
[1] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium
[2] Georges Pompidou European Hosp, Dept Med Oncol, Paris, France
[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.388
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
388
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma
    Edeline, J.
    Laguerre, B.
    Rolland, Y.
    Patard, J. -J.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 186 - 187
  • [32] Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
    Gomez-Abuin, Gonzalo
    Amelia Karam, Aida
    Aristides Mezzadri, Norberto
    Arturo Bas, Carlos
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 62 - 63
  • [33] Re: Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma
    Delahunt, Brett
    Bethwaite, Peter B.
    Miller, Rose J.
    Sika-Paotonu, Dianne
    Srigley, John R.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 356 - 357
  • [34] Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
    Ondřej Fiala
    Pavel Ostašov
    Aneta Rozsypalová
    Milan Hora
    Ondřej Šorejs
    Jan Šustr
    Barbora Bendová
    Ivan Trávníček
    Jan Filipovský
    Jindřich Fínek
    Tomáš Büchler
    Targeted Oncology, 2021, 16 : 643 - 652
  • [35] Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
    Fiala, Ondrej
    Ostasov, Pavel
    Rozsypalova, Aneta
    Hora, Milan
    Sorejs, Ondrej
    Sustr, Jan
    Bendova, Barbora
    Travnicek, Ivan
    Filipovsky, Jan
    Finek, Jindrich
    Buchler, Tomas
    TARGETED ONCOLOGY, 2021, 16 (05) : 643 - 652
  • [36] Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically
    Antoni Vilaseca
    Daniel P. Nguyen
    Emily A. Vertosick
    Renato B. Corradi
    Mireia Musquera
    Meritxell Pérez
    Nicola Fossati
    Daniel D. Sjoberg
    Ramon Farré
    Isaac Almendros
    Josep M. Montserrat
    Nicole E. Benfante
    A. Ari Hakimi
    Anders J. Skanderup
    Paul Russo
    Antonio Alcaraz
    Karim A. Touijer
    World Journal of Urology, 2017, 35 : 51 - 56
  • [37] Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
    Song, Yan
    Du, Chunxia
    Zhang, Wen
    Sun, Yongkun
    Yang, Lin
    Cui, Chengxu
    Chi, Yihebali
    Shou, Jianzhong
    Zhou, Aiping
    Wang, Jinwan
    Sun, Yan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 258.e15 - 258.e22
  • [38] Prognostic impact of baseline serum C-reactive protein in metastatic renal cell carcinoma treated with sunitinib
    Yann-Alexandre, Vano
    Beuselinck, Benoit
    Wolter, Pascal
    Teghom, Corine
    Philip, Debruyne
    Karadimou, Alexandra
    Lerut, Evelyne
    Robert, Paridaens
    Schoeffski, Patrick
    Oudard, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [39] Differential response of patients with metastatic renal cell carcinoma to sunitinib according to the Fuhrman grading of their targeted tumors.
    Visvardis, E.
    Waxman, J.
    Savage, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Prognostic value of Fuhrman's grade in renal cell carcinoma. A study of 170 cases
    Dupre, F
    Guyetant, S
    Chautard, D
    Burtin, P
    Saint-Andre, JP
    ANNALES DE PATHOLOGIE, 1998, 18 (02) : 88 - 97
12345